BFLY · Butterfly Network, Inc.
$9.17
+0.00 (+0.00%)
At close · Aug 20
Market Cap
$2.40B
Shares
266.29M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.17
Open$9.01
Day$8.95–9.41
52W close$1.39–9.70
Avg vol 30d7.1M
Short int32.7M · 12.3% float · 4.3d
Short vol56%
Last earningsJul 30, 2026
DataJul 2020–Aug 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 29, 2026
Est · unconfirmed
· in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Strong Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+90%
above
Price vs 50-day avg
+19%
above
RSI (14)
60
neutral
MACD trend
Positive
52-week position
94%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+39%
trailing
6-month return
+142%
trailing
YTD return
+141%
this year
Relative strength
+131%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $8 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
+2% holders QoQ · +45 funds added
Insider flow
Distributing
Net -$40.9M over 90 days · 88% sells
Short interest
Rising
12.28% of float · ▲ +4.6% MoM · 4.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
246 holders — near 3-yr high, broad support
Squeeze score
78
high risk · 0–100
Fundamentals
Revenue growth
+19%
Y/Y
Gross margin
47%
contracting
EPS growth
+9%
Y/Y
Free cash flow
$-16.0M
Balance sheet
$150.5M
net cash
Quant / Vol
risk profile
Volatility
126%
annualized · 1-yr
Max drawdown
−41%
past year
ATR
7.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Jul 30, 2026
Revenue
· Fiscal Year 2026
Initiated
$119M – $123M
prior FY $97.61M
midpoint +24.0% Y/Y
Prior guidance
period ended
· from the 8-K filed Oct 31, 2025
Revenue
· Fiscal Year 2025
$91M – $95M
Guided vs delivered
· last 1 settled
Revenue
Fiscal Year 2025
guided $91M – $95M
$97.61M
Beat +5.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+90%
Bullish
Price vs 50-day avg
+19%
Bullish
RSI (14)
60
Neutral
MACD trend
Positive
Bullish
52-week position
94%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $8 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
+2% holders QoQ · +45 funds added
Insider flow
Distributing
Net -$40.9M over 90 days · 88% sells
Short interest
Rising
12.28% of float · ▲ +4.6% MoM · 4.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
246 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1
Now $9 · 94%
Range high $10
vs 200-day avg +90%
vs 50-day avg +19%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -7.51M | Six months ended June 30, 2026 | — |
|
|
|||
| Adjusted EBITDA loss non-GAAP | $1.4M | second quarter of 2026 | — |
| Adjusted EPS non-GAAP | -$0.04 | Six months ended June 30, 2026 | — |
| Adjusted gross margin non-GAAP | 70.3% | Six months ended June 30, 2026 | — |
| Adjusted gross profit non-GAAP | 41.57M | Six months ended June 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BFLY
this stock
Butterfly Network, Inc.
|
$2.40B | +141.3% | +19.0% | — | 12.3% |
|
ABT
Abbott Laboratories
|
$198.81B | -8.9% | +5.7% | 32.0 | 1.3% |
|
SYK
Stryker Corp
|
$127.26B | -6.8% | +11.2% | 34.4 | 2.2% |
|
MDT
Medtronic plc
|
$120.49B | -3.9% | +8.4% | 25.2 | 1.4% |
|
BSX
Boston Scientific Corp
|
$73.14B | -48.2% | +12.5% | 20.4 | 1.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BFLY | +3.5% | +38.5% | +142.0% | +29.0% | +141.3% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +5.5% | +35.2% | +130.8% | +26.9% | +129.5% |
Key facts
CIK
1804176
CUSIP
124155102
13F (30d)
228 filings
224 filers
Visit website
Investor relations